Connecting hospitalized patients to alcohol care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study compares two approaches for initiating alcohol-use treatment: in-hospital sessions with an outreach therapist over up to six months, and providing information to pursue care at an alcohol treatment center outside the hospital. It aims to measure feasibility for a future definitive randomized trial with concealed allocation and blinded outcome assessment. Participants are adults hospitalized or seen in outpatient clinics at Zealand University Hospital Køge with ICD-10 codes for alcohol dependence or harmful use. The study focuses on implementation outcomes and will inform whether a larger trial can be conducted to test effectiveness in improving engagement with treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Hospitalised or seen in an outpatient clinic at SUH Køge
* Full-filling international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use
* Informed written consent
* Being able to meet the AUD therapist in connection with a hospital visit with a health condition wholly or partly attributable to alcohol

Exclusion Criteria:

* Ongoing specialized treatment for AUD
* Not speaking Danish
* Not living in the catchment area of Zealand University hospital
* Age \< 18 years
* Enrolled in the Zealand alcohol-related liver disease cohort study

Where it's running

• Zealand University Hospital, Department of Medicine
  Køge, Denmark Recruiting

Study contacts

• Principal investigator: Gro Askgaard — Sjaellands Universitetshospital Køge, Medicinsk Afdeling
• Study coordinator: Gro Askgaard, MD, PhD
• Email: gras@regionsjaelland.dk
• Phone: 60142280

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

• Thiamine to reduce brain injury in adults with alcohol use disorder

  This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.

  Recruiting Phase 2 Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT07844720

• Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit

  This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.

  Recruiting Brandeis University · Detroit, Michigan · NCT07724275

• Path180: a computer-based skills program to help teens reduce alcohol use

  This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.

  Recruiting Brown University · Providence, Rhode Island · NCT07713251

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)

  This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.

  Recruiting Phase 3 Centre Hospitalier Universitaire de Nīmes · Bayonne and 7 other locations · NCT07638553

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.